Showing results (301-310 of 623) with videos related to
Sort By:
Pageof 63
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy malesS M Huang, L Brusser, S C Chien, et al.American Journal of Clinical Oncology|February 1, 1989
Phase II trial of N-methylformamide in advanced renal cancerJ S Abrams, N Tait, H Silva, et al.Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1988
Functional heterogeneity among human inducer T cell clonesD T Umetsu, H H Jabara, R H DeKruyff, et al.Cancer Gene Therapy|July 1, 1997
In vivo gene inoculation of a recombinant single-chain antitumor antibody induces anti-immunoglobulin responseG L Prasad, H S Lee, M Iwahashi, et al.Urologic Oncology|January 2, 2022
Oncologic outcomes of organ-confined Gleason grade group 4-5 prostate cancer after radical prostatectomyFelix Preisser, Nuowei Wang, Raisa S Abrams-Pompe, et al.The Journal of Clinical Investigation|March 1, 1992
Local cytokine production in a murine model of Escherichia coli pyelonephritisH S Rugo, P O'Hanley, A G Bishop, et al.Cancer Research|December 15, 1992
Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primateJ Kantor, K Irvine, S Abrams, et al.Journal of the National Cancer Institute|October 19, 2013
Statistical and practical considerations for clinical evaluation of predictive biomarkersMei-Yin C Polley, Boris Freidlin, Edward L Korn, et al.The New England Journal of Medicine|November 30, 1995
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06M C Christian, M S McCabe, E L Korn, et al.Pageof 63